ATLERADSTROCEL
UNII UP6VVX52H0

Substance Identification & Data

This profile provides standardized clinical and technical data for Atleradstrocel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) UP6VVX52H0.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
UP6VVX52H0
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ATLERADSTROCEL
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C171651
National Cancer Institute reference terminology for clinical and research data.
INN ID
11082
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
ITIS TSN
180092
Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.
NCBI Taxonomy
9606
Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Atleradstrocel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ATLERADSTROCEL

Common Names & Synonyms

ATLERADSTROCEL [INN]
HUMAN CULTURE EXPANDED AUTOLOGOUS ADIPOSE STROMAL PROGENITOR CELLS (ASC) FOR CELL-BASED THERAPY. THE CELLS EXPRESS CD73 AND CD90 CELL SURFACE MARKERS AND ARE NEGATIVE FOR CD31, CD34 AND CD45 MARKERS

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus